| Drug Interaction Between Daclatasvir/Asunaprevir/BMS-791325 and Rosuvastatin (NCT02104843) | Bristol-Myers Squibb | 2014-04-01 |
| The Effects of Caffeine on Pain-Based Pacing During a Cycling Time-Trial (NCT02115763) | University of Oklahoma | 2014-04-01 |
| Effect of Denosumab on Cellular Biomarkers in the Human Breast (NCT02099461) | Amgen | 2014-04-01 |
| The Effect of Antacids and Multivitamins on Raltegravir (NCT01784302) | Helen Reynolds | 2014-04-01 |
| A Two-arm, Single Center Phase 1b Trial of Bavituximab Plus Ipilimumab in Advanced Melanoma Patients (NCT01984255) | University of Texas Southwestern Medical Center | 2014-04-01 |
| Can Fat Derived Stem Cells (SVF) be Used in the Treatment of Erectile Dysfunction After Prostatectomy (NCT02240823) | Martha Haahr M.D | 2014-04-01 |
| The ONE Study UK Treg Trial (NCT02129881) | Guy's and St Thomas' NHS Foundation Trust | 2014-04-01 |
| Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD) (NCT02195323) | Royan Institute | 2014-04-01 |
| Does the Sara Combilizer®, an Early Mobilization Aid, Reduce the Time Taken to First Mobilise Ventilated Patients in Intensive Care? (NCT03143777) | University Hospital Birmingham NHS Foundation Trust | 2014-04-01 |
| A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis (NCT02103725) | LEO Pharma | 2014-04-01 |
| Safety and Preliminary Efficacy Study of V404 PDS in Uveitis (NCT02125266) | Forsight Vision4 | 2014-04-01 |
| Rediscovering Hydroxychloroquine as a Novel Insulin Sensitizer (NCT02124681) | University of Pittsburgh | 2014-04-01 |
| To Assess the Effect of Itraconazole and Fluconazole on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers (NCT02093728) | AstraZeneca | 2014-04-01 |
| Effects of Hallucinogens and Other Drugs on Mood and Performance (NCT02033707) | Johns Hopkins University | 2014-04-01 |
| Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis Pigmentosa (NCT02709876) | Stem Cells Arabia | 2014-04-01 |
| Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis (NCT02115516) | Sanaria Inc. | 2014-04-01 |
| Phototoxicity Test of Dapsone Gel in Healthy Volunteers (NCT02108483) | Almirall, S.A. | 2014-04-01 |
| A Safety Study to Investigate the Skin Sensitization Potential of MFC51123 (NCT02192203) | GlaxoSmithKline | 2014-04-01 |
| Mass Balance Study of 14C-labelled GFT505 in Healthy Volunteers (NCT02142127) | Genfit | 2014-04-01 |
| A Study to Assess the Interaction Between ASP1707 and Itraconazole in Healthy Female Subjects (NCT02175407) | Astellas Pharma Europe B.V. | 2014-04-01 |
| Dose Proportionality Study Of PF-00345439 Formulation Under Fed Conditions (NCT02089295) | Pain Therapeutics | 2014-04-01 |
| Safety Study of Fenretinide in Adult Patients With Cystic Fibrosis (NCT02141958) | Elias Matouk | 2014-04-01 |
| Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant (NCT02065869) | Bellicum Pharmaceuticals | 2014-04-01 |
| Single-Dose, Crossover Study To Compare Bioavailability Of Two Formulations Under Fed And Fasted Conditions (NCT02059915) | Pain Therapeutics | 2014-04-01 |
| Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO) (NCT02050347) | Baylor College of Medicine | 2014-04-01 |
| Enhancing Delivery of Problem Solving Therapy Using SmartPhone Technology (NCT01891734) | VA Office of Research and Development | 2014-04-01 |
| Lesinurad Tablet Bioequivalence (NCT02127775) | Ardea Biosciences, Inc. | 2014-04-01 |
| Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers (NCT02108288) | Otsuka Pharmaceutical Co., Ltd. | 2014-04-01 |
| Investigator Initiated Phase 1 Study of TBI-1201 (NCT02096614) | Mie University | 2014-04-01 |
| A Study of Cephalexin in Healthy Participants (NCT02100826) | Eli Lilly and Company | 2014-04-01 |
| Tamoxifen Treatment in Patients With Motor Neuron Disease (NCT02166944) | Taipei Medical University Shuang Ho Hospital | 2014-04-01 |
| An Evaluation of Web Based Pulmonary Rehabilitation (NCT02404831) | University of Glasgow | 2014-04-01 |
| A Trial Investigating the Influence of Injection Speed and Volume on the Perception of Subcutaneous Injection Pain (NCT01937702) | Profil Institut für Stoffwechselforschung GmbH | 2014-04-01 |
| Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers (NCT01353937) | NYU Langone Health | 2014-04-01 |
| Enhancement by Poly-ICLC During HIV-1 Infection (NCT02071095) | Nina Bhardwaj | 2014-04-01 |
| Effects of Food on Oxycodone Pharmacokinetics in Healthy Volunteers (NCT02117583) | Pain Therapeutics | 2014-04-01 |
| Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian Volunteers (NCT02119091) | Haiyan Li | 2014-04-01 |
| Bioequivalence of a FDC Tablet of Linagliptin/Metformin (5mg/1000mg) Extended Release in Healthy Subjects (NCT02084082) | Boehringer Ingelheim | 2014-04-01 |
| ALX-0061 Phase I Bioavailability Study in Healthy Volunteers (NCT02101073) | Ablynx, a Sanofi company | 2014-03-31 |
| Trial of Olaparib in Combination With AZD5363 (ComPAKT) (NCT02338622) | Royal Marsden NHS Foundation Trust | 2014-03-31 |
| Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody for Injection (NCT04170595) | Genor Biopharma Co., Ltd. | 2014-03-28 |
| Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors (NCT02095132) | National Cancer Institute (NCI) | 2014-03-28 |
| A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC) (NCT02079636) | Eli Lilly and Company | 2014-03-28 |
| A Study to Determine the Effect of 500 mg Oral Dose of KD025 in Healthy Male and Post-menopausal Female Subjects (NCT05918614) | Kadmon, a Sanofi Company | 2014-03-28 |
| Safety, Pharmacokinetics, and Pharmacodynamics of Ruzasvir (MK-8408) in Participants With Hepatitis C Infection (MK-8408-003) (NCT02076100) | Merck Sharp & Dohme LLC | 2014-03-27 |
| Effect of Dosing Time and Meal on IN-105 (Insulin Tregopil) PK and PD (NCT03392961) | Biocon Limited | 2014-03-27 |
| Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD) (NCT01954979) | Beth Israel Deaconess Medical Center | 2014-03-27 |
| Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia (NCT02096510) | Haukeland University Hospital | 2014-03-27 |
| Trametinib and Navitoclax in Treating Patients With Advanced or Metastatic Solid Tumors (NCT02079740) | National Cancer Institute (NCI) | 2014-03-26 |
| Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia (NCT01743807) | Therapeutic Advances in Childhood Leukemia Consortium | 2014-03-26 |
| Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on the Myopathy of Cystinosis (NCT02124070) | National Human Genome Research Institute (NHGRI) | 2014-03-26 |
| Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma (NCT01479842) | Kami Maddocks, MD | 2014-03-26 |
| A Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Doravirine (MK-1439) (MK-1439-019) (NCT02089659) | Merck Sharp & Dohme LLC | 2014-03-26 |
| A Study to Learn How Finerenone (BAY94-8862) Moves Into, Through and Out of the Body, How it Affects the Body, and How Safe it is in Adult Participants With Different Degrees of Reduced Liver Function and in Healthy Participants With Similar Age, Weight and Gender Distribution (NCT04881994) | Bayer | 2014-03-25 |
| Neuroimmune Response to Lipopolysaccharide (NCT04233593) | Yale University | 2014-03-25 |
| Pilot Study of Redirected Autologous T Cells Engineered to Contain Humanized Anti-CD19 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma Previously Treated With Cell Therapy (NCT02374333) | University of Pennsylvania | 2014-03-25 |
| A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies (NCT02038777) | Pfizer | 2014-03-25 |
| Relative Bioavailability Study With BMS-955176 (NCT02095886) | ViiV Healthcare | 2014-03-25 |
| MEDI4736 (Anti PD-L1) Combined With Gefitinib in Subjects With Non-Small Cell Lung Cancer(NSCLC). (NCT02088112) | MedImmune LLC | 2014-03-24 |
| Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions (NCT02075619) | GlaxoSmithKline | 2014-03-24 |
| Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma (NCT01989585) | National Cancer Institute (NCI) | 2014-03-24 |
| Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus (NCT02052739) | Supernus Pharmaceuticals, Inc. | 2014-03-21 |
| A Safety and Efficacy Study of LGH447 in Patients With Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS) (NCT02078609) | Novartis Pharmaceuticals | 2014-03-20 |
| Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl in Patients With Chronic Hepatitis C (NCT02118012) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-03-20 |
| Safety, Tolerability, and Pharmacokinetics of Single Doses BI 425809 (NCT02068690) | Boehringer Ingelheim | 2014-03-20 |
| A Clinical Study of Paclitaxel Cationic Liposomes for the Treatment of Patients With Advanced Solid Tumors (NCT06632574) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2014-03-19 |
| Mass Balance, Pharmacokinetics and Metabolism Study of IXAZOMIB (NCT01953783) | Millennium Pharmaceuticals, Inc. | 2014-03-19 |
| A Study of Tralokinumab When Delivered Subcutaneously at Different Flow Rates to Healthy Volunteers (NCT02085473) | MedImmune LLC | 2014-03-19 |
| Regorafenib and Cetuximab in Patients With Advanced Malignancy (NCT02095054) | M.D. Anderson Cancer Center | 2014-03-19 |
| CKD-337 Drug Interaction Study (NCT02066207) | Chong Kun Dang Pharmaceutical | 2014-03-18 |
| Safety and Tolerability of Pembrolizumab (MK-3475) + Pegylated Interferon Alfa-2b and Pembrolizumab+ Ipilimumab in Participants With Advanced Melanoma or Renal Cell Carcinoma (MK-3475-029/KEYNOTE-29) (NCT02089685) | Merck Sharp & Dohme LLC | 2014-03-17 |
| A Trial Comparing the Pharmacokinetic Properties of Faster-acting Insulin Aspart (FIAsp) After Different Injection Regions and Routes of Administration in Healthy Subjects (NCT02089451) | Novo Nordisk A/S | 2014-03-17 |
| The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 100mg Compared With Compressed Tablet 100 mg (NCT02064465) | GlaxoSmithKline | 2014-03-15 |
| A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, Food Effects, and Drug-drug Interactions of ACP-196 in Healthy Participants (NCT04901923) | Acerta Pharma BV | 2014-03-15 |
| Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (NCT02077166) | Pharmacyclics LLC. | 2014-03-13 |
| Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment (NCT01894243) | AstraZeneca | 2014-03-13 |
| A Study to Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies (NCT02061761) | Bristol-Myers Squibb | 2014-03-13 |
| TGR-1202, a PI3K Delta Inhibitor, in Combination With Obinutuzumab and Chlorambucil in Patients With Chronic Lymphocytic Leukemia (CLL) (NCT02100852) | TG Therapeutics, Inc. | 2014-03-12 |
| Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients (NCT02000817) | GlaxoSmithKline | 2014-03-12 |
| Safety, Tolerability, and Pharmacokinetics of Andecaliximab in Adults With Chronic Obstructive Pulmonary Disease (COPD) (NCT02077465) | Gilead Sciences | 2014-03-11 |
| Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis (NCT02039401) | Helixmith Co., Ltd. | 2014-03-11 |
| A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread (NCT02057133) | Eli Lilly and Company | 2014-03-10 |
| Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction (NCT02070549) | National Cancer Institute (NCI) | 2014-03-10 |
| Comparative PK PD Study in PAH Patients (Fox vs. I-Neb) (NCT02032836) | Bayer | 2014-03-10 |
| Safety of Sublingual dmLT for ETEC (NCT02052934) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-03-10 |
| Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma (NCT01896999) | National Cancer Institute (NCI) | 2014-03-07 |
| LDK378 in Adult Chinese Patients With ALK-rearranged (ALK-positive) Advanced Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib (NCT02040870) | Novartis Pharmaceuticals | 2014-03-07 |
| A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer (NCT02082210) | Eli Lilly and Company | 2014-03-07 |
| Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant (NCT02083250) | M.D. Anderson Cancer Center | 2014-03-06 |
| Depression Treatment and Risk for Cardiovascular Disease (NCT06170255) | East Carolina University | 2014-03-06 |
| Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With Placebo (NCT02079870) | Novo Nordisk A/S | 2014-03-06 |
| Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain (NCT02078089) | Costantine Albany | 2014-03-06 |
| Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD (NCT02027805) | Xenikos | 2014-03-05 |
| Evaluation of a Novel Positron Emission Tomography (PET Radiotracer for TARP Gamma-8 (NCT02108015) | National Institute of Mental Health (NIMH) | 2014-03-05 |
| A Study to Evaluate the Potential Benefit of the Addition of BYL719 to Paclitaxel in the Treatment of Breast Cancer and Head-and-neck Cancer (NCT02051751) | Novartis Pharmaceuticals | 2014-03-05 |
| Pomalidomide, Dexamethasone, and Filgrastim-sndz in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT01946152) | M.D. Anderson Cancer Center | 2014-03-05 |
| Phase I Dose-finding and Preliminary Efficacy Study of the Istodax® in Combination With Doxil® for the Treatment of Adults With Relapsed or Refractory Cutaneous T-cell Lymphoma (NCT01902225) | Weiyun Ai | 2014-03-04 |
| The Effect of Platelet Rich Plasma Injection Combined With Exercise Rehabilitation in Patients With Rotator Cuff Tear (NCT03548662) | Taipei Veterans General Hospital, Taiwan | 2014-03-04 |
| Lenalidomide and Pidilizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT02077959) | Ohio State University Comprehensive Cancer Center | 2014-03-03 |
| A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone (NCT01288573) | Genzyme, a Sanofi Company | 2014-03-03 |